share_log

Virpax Pharmaceuticals | 4: Statement of changes in beneficial ownership of securities-Director Herman Gary L

Virpax Pharmaceuticals | 4: Statement of changes in beneficial ownership of securities-Director Herman Gary L

Virpax製藥 | 4:持股變動聲明-董事 Herman Gary L
美股SEC公告 ·  07/10 04:06

牛牛AI助理已提取核心訊息

In a recent transaction, Gary L Herman, associated with Virpax Pharmaceuticals Inc. [VRPX], executed a stock transaction on 07/05/2024. The specific details regarding the nature of the shares, the number of shares transacted, the transaction price, and the resulting total value of shares held post-transaction were not disclosed. The action type and status of the transaction were also not provided in the announcement.
In a recent transaction, Gary L Herman, associated with Virpax Pharmaceuticals Inc. [VRPX], executed a stock transaction on 07/05/2024. The specific details regarding the nature of the shares, the number of shares transacted, the transaction price, and the resulting total value of shares held post-transaction were not disclosed. The action type and status of the transaction were also not provided in the announcement.
在最近的一次交易中,Virpax Pharmaceuticals Inc. [VRPX]的Gary L Herman進行了一次股票交易,交易日期爲2024年07月05日。有關交易的股票性質、交易的股票數量、交易價格以及交易後持有的股票總價值的具體細節未公開。該公告也未提供交易的操作類型和狀態幣。
在最近的一次交易中,Virpax Pharmaceuticals Inc. [VRPX]的Gary L Herman進行了一次股票交易,交易日期爲2024年07月05日。有關交易的股票性質、交易的股票數量、交易價格以及交易後持有的股票總價值的具體細節未公開。該公告也未提供交易的操作類型和狀態幣。

譯文內容由第三人軟體翻譯。


牛牛AI助手部分由第三方人工智慧模型基於資訊內容自動產生,只对除中国内地以外的地区提供。


以上內容僅用作資訊或教育之目的,不構成與富途相關的任何投資建議。富途竭力但無法保證上述全部內容的真實性、準確性和原創性。